RecruitingNCT07112599

Study of Predicting Lymph Node Metastasis of High-risk Prostate Cancer by Artificial Intelligence Multi-omics Analysis

Clinical Study on Predicting Lymph Node Metastasis of High-risk Prostate Cancer Based on Artificial Intelligence Multi-omics Analysis:A Multicenter, Prospective and Observational Clinical Study


Sponsor

Anhui Medical University

Enrollment

2,000 participants

Start Date

Jan 25, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

The pathological-omics and imaging-omics in this study are combined to construct an artificial intelligence (AI) model that can predict whether high-risk prostate cancer patients may have lymph node metastasis. The model determines whether the patient has lymph node metastasis based on the MRI results and the pathological section image information of the case combined with clinical data before radical resection of the prostate. This study is a multicenter, prospective clinical study to verify the model's ability to predict whether high-risk prostate cancer patients may have lymph node metastasis.


Eligibility

Sex: MALEMin Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This study is developing an AI-based tool to predict whether high-risk prostate cancer has spread to nearby lymph nodes, using imaging data. Accurate lymph node prediction can help doctors decide whether to remove lymph nodes during surgery and plan radiation therapy, potentially sparing some patients unnecessary procedures. **You may be eligible if...** - You are 50 years or older - You have confirmed prostate adenocarcinoma - You have high-risk features: PSA of 20 or above, or a Gleason score (tumor aggressiveness rating) of 8 or higher - You are in reasonable health (ECOG 0-2) with life expectancy at least 6 months - Your blood counts, liver, kidney, and heart function meet required levels - Your blood pressure is within acceptable range **You may NOT be eligible if...** - You do not meet the PSA or Gleason score thresholds - You have significant heart, liver, or kidney problems outside acceptable ranges - Your blood pressure or blood counts are outside required ranges Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Science and Technology Institute, Anhui Medical University

Hefei, Anhui, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07112599


Related Trials